229 related articles for article (PubMed ID: 32011447)
1. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol.
Leng Y; Fu X; Qian L; Li Q; Gao H; Xie H; Xie C
BMC Complement Med Ther; 2022 Dec; 22(1):337. PubMed ID: 36550516
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine Shenqi compound to improve lower extremity atherosclerosis of patients with type 2 diabetes by affecting blood glucose fluctuation: Study protocol for a randomized controlled multicenter trial.
Zhu Q; Kang J; Xu G; Li J; Zhou H; Liu Y
Medicine (Baltimore); 2020 Mar; 99(11):e19501. PubMed ID: 32176092
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
[TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial.
Yu XQ; Yang SG; Xie Y; Li JS
J Integr Med; 2020 Mar; 18(2):163-168. PubMed ID: 31928920
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese medicine for stable angina pectoris via TCM pattern differentiation and TCM mechanism: study protocol of a randomized controlled trial.
Zhang Z; Zhang F; Wang Y; Du Y; Zhang H; Kong D; Liu Y; Yang G
Trials; 2014 Oct; 15():422. PubMed ID: 25359307
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Wang L; Xiang L; Piao S; Gong X; Zhou W; Feng W; Li H; Li L; Wei A; Zhu Q; Rong X; Guo J
Diabetes Metab Syndr Obes; 2021; 14():2651-2659. PubMed ID: 34163193
[TBL] [Abstract][Full Text] [Related]
8. Effects of sang-qi granules on blood pressure and endothelial dysfunction in stage I or II hypertension: study protocol for a randomized double-blind double-simulation controlled trial.
Shi H; Yang D; Qiao J; Sun R; Li R; Zhu C; Jing R; Liu L; Huang L; Li L
Trials; 2020 Jan; 21(1):12. PubMed ID: 31907056
[TBL] [Abstract][Full Text] [Related]
9. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
10. Chinese herbal medicine TangBi Formula treatment of patients with type 2 diabetic distal symmetric polyneuropathy disease: study protocol for a randomized controlled trial.
Jin D; Huang WJ; Meng X; Yang F; Zheng YJ; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL
Trials; 2017 Dec; 18(1):631. PubMed ID: 29284520
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Zhou X; Yan DM; Zhu WF; Liu WJ; Nie HY; Xu S; Jiang YP; Zhang KH; Fu Y; Wan YY; Yu XY; Li H; Sun X; Chen XF
Trials; 2019 Jun; 20(1):343. PubMed ID: 31182140
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial.
Lo LC; Chen CY; Chen ST; Chen HC; Lee TC; Chang CS
Trials; 2012 Dec; 13():232. PubMed ID: 23206440
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
Wang TF; Xue XL; Zhang YJ; Han P; Li Z; Wang WP; Xing JM; Wang QB; Tang Y; Li L; Wang JJ; Li GR; Ji SL; Wu LX; Zhao Y; Wu XY; Zhao RS
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):515-24. PubMed ID: 21565137
[TBL] [Abstract][Full Text] [Related]
14. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
[TBL] [Abstract][Full Text] [Related]
15. Clinical study for external washing by traditional Chinese medicine in the treatment of multiple infectious wounds of diabetic foot: Study protocol clinical trial (SPIRIT compliant).
Zhang Y; Yuan H; Kang J; Xie H; Long X; Qi L; Xie C; Gong G
Medicine (Baltimore); 2020 Apr; 99(17):e19841. PubMed ID: 32332634
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX
Trials; 2018 May; 19(1):275. PubMed ID: 29747670
[TBL] [Abstract][Full Text] [Related]
17. Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial.
Sun Y; Chen X; Zhang L; Yuan WA; Chen Q; Zhang YB; Liu LJ; Zhang W; Sun M
Drug Des Devel Ther; 2022; 16():4251-4267. PubMed ID: 36540716
[TBL] [Abstract][Full Text] [Related]
18. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H
Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157
[TBL] [Abstract][Full Text] [Related]
19. Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial.
He H; Chen G; Gao J; Liu Y; Zhang C; Liu C; Li H; He Q; Li J; Wang J
Trials; 2018 Sep; 19(1):515. PubMed ID: 30241562
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial.
Zhao XM; Zhang Y; He XH; Chen HD; Wang ZF; Guo J; Wang XM; Gao ZZ; Wang JP; Liu W; Zhao LH; Tong XL
Trials; 2018 Mar; 19(1):200. PubMed ID: 29587863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
